It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BMRA’s FA Score shows that 1 FA rating(s) are green whileCALZF’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BMRA’s TA Score shows that 3 TA indicator(s) are bullish while CALZF’s TA Score has 5 bullish TA indicator(s).
BMRA (@Medical/Nursing Services) experienced а -3.78% price change this week, while CALZF (@Medical/Nursing Services) price change was -1.43% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.03%. For the same industry, the average monthly price growth was +0.41%, and the average quarterly price growth was +3.73%.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
BMRA | CALZF | BMRA / CALZF | |
Capitalization | 7.92M | 516M | 2% |
EBITDA | -4.71M | N/A | - |
Gain YTD | 29.540 | -19.837 | -149% |
P/E Ratio | N/A | 152.71 | - |
Revenue | 5.68M | N/A | - |
Total Cash | 3.06M | N/A | - |
Total Debt | 543K | N/A | - |
BMRA | CALZF | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 29 Undervalued | 88 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 95 | |
PRICE GROWTH RATING 1..100 | 62 | 63 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 12 | 11 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BMRA's Valuation (29) in the Medical Specialties industry is somewhat better than the same rating for CALZF (88) in the null industry. This means that BMRA’s stock grew somewhat faster than CALZF’s over the last 12 months.
BMRA's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as CALZF (100) in the null industry. This means that BMRA’s stock grew similarly to CALZF’s over the last 12 months.
CALZF's SMR Rating (95) in the null industry is in the same range as BMRA (98) in the Medical Specialties industry. This means that CALZF’s stock grew similarly to BMRA’s over the last 12 months.
BMRA's Price Growth Rating (62) in the Medical Specialties industry is in the same range as CALZF (63) in the null industry. This means that BMRA’s stock grew similarly to CALZF’s over the last 12 months.
BMRA's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as CALZF (100) in the null industry. This means that BMRA’s stock grew similarly to CALZF’s over the last 12 months.
BMRA | CALZF | |
---|---|---|
RSI ODDS (%) | 4 days ago86% | 4 days ago72% |
Stochastic ODDS (%) | 4 days ago84% | 4 days ago75% |
Momentum ODDS (%) | 4 days ago90% | 4 days ago67% |
MACD ODDS (%) | 4 days ago86% | N/A |
TrendWeek ODDS (%) | 4 days ago86% | 4 days ago69% |
TrendMonth ODDS (%) | 4 days ago86% | 4 days ago60% |
Advances ODDS (%) | 21 days ago79% | 19 days ago73% |
Declines ODDS (%) | 5 days ago84% | N/A |
BollingerBands ODDS (%) | 4 days ago90% | 4 days ago67% |
Aroon ODDS (%) | 4 days ago89% | 4 days ago57% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
UIGIX | 25.35 | 0.18 | +0.72% |
Victory Growth & Income Institutional | |||
SUTZX | 16.34 | 0.11 | +0.68% |
AB Sustainable US Thematic Z | |||
FSHOX | 125.74 | 0.64 | +0.51% |
Fidelity Select Construction & Housing | |||
NWHLX | 11.18 | 0.05 | +0.45% |
Nationwide Bailard Intl Eqs M | |||
UBVSX | 82.49 | 0.12 | +0.15% |
Undiscovered Managers Behavioral Val I |
A.I.dvisor tells us that BMRA and LFWD have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMRA and LFWD's prices will move in lockstep.
Ticker / NAME | Correlation To BMRA | 1D Price Change % | ||
---|---|---|---|---|
BMRA | 100% | N/A | ||
LFWD - BMRA | 29% Poorly correlated | -1.51% | ||
SENS - BMRA | 28% Poorly correlated | +7.02% | ||
CALZF - BMRA | 26% Poorly correlated | N/A | ||
POAI - BMRA | 25% Poorly correlated | +0.97% | ||
NOTV - BMRA | 24% Poorly correlated | -6.63% | ||
More |
A.I.dvisor tells us that CALZF and ZJYL have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CALZF and ZJYL's prices will move in lockstep.
Ticker / NAME | Correlation To CALZF | 1D Price Change % | ||
---|---|---|---|---|
CALZF | 100% | N/A | ||
ZJYL - CALZF | 32% Poorly correlated | +2.83% | ||
ZIMV - CALZF | 29% Poorly correlated | -0.21% | ||
BMRA - CALZF | 26% Poorly correlated | N/A | ||
KSRBF - CALZF | 23% Poorly correlated | N/A | ||
CBSC - CALZF | 5% Poorly correlated | N/A | ||
More |